1. Home
  2. BYFC vs NSPR Comparison

BYFC vs NSPR Comparison

Compare BYFC & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadway Financial Corporation

BYFC

Broadway Financial Corporation

HOLD

Current Price

$7.82

Market Cap

70.0M

Sector

Finance

ML Signal

HOLD

Logo InspireMD Inc.

NSPR

InspireMD Inc.

N/A

Current Price

$1.65

Market Cap

77.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BYFC
NSPR
Founded
1946
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.0M
77.5M
IPO Year
2013
2009

Fundamental Metrics

Financial Performance
Metric
BYFC
NSPR
Price
$7.82
$1.65
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
1.5K
24.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.32
EPS
N/A
N/A
Revenue
$155,000.00
$2,310,000.00
Revenue This Year
N/A
$22.91
Revenue Next Year
N/A
$72.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.51
$1.51
52 Week High
$8.85
$2.94

Technical Indicators

Market Signals
Indicator
BYFC
NSPR
Relative Strength Index (RSI) 45.82 43.00
Support Level $7.69 $1.56
Resistance Level $7.85 $2.47
Average True Range (ATR) 0.07 0.08
MACD -0.04 -0.01
Stochastic Oscillator 25.41 23.33

Price Performance

Historical Comparison
BYFC
NSPR

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: